Document is current
Any future updates will be listed below
-
Authors
Huang, Fei
Wei, Ran
Zhou, Sicheng
Mei, Shiwen
Xiao, Tixian
Xing, Wei
Liu, Qian
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04850027 at ClinicalTrials.govDocuments that mention this clinical trial
The diagnosis and oncological outcomes of obturator and internal iliac lymph node metastasis in middle–low rectal cancer: results of a multicenter Lateral Node Collaborative Group study in China
https://doi.org/10.1007/s12672-024-01500-4
Neoadjuvant chemotherapy with FOLFOXIRI plus lateral lymph nodes dissection for the treatment of resectable rectal cancer with lateral lymph node metastasis: A single-arm, investigator-initiated, phase II trial.
https://doi.org/10.1200/jco.2024.42.16_suppl.3533
-
Funding
Funding for this research was provided by:
the National Key Research and Development Program/Prevention and Treatment Research on Commonly Occurring and Prevalent Diseases (No. 2022YFC2505003)
the Medicine and Health Technology Innovation Project of the Chinese Academy of Medical Sciences (No. 2017-12 M-1e006)
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 1 November 2024
First Online: 4 November 2024
Declarations
:
: The study protocol and all amendments were approved by the ethics committee of the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (NCC2022C-325). Written informed consent was obtained from individual or guardian participants.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.
